載入...
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
BACKGROUND: The ongoing COVID-19 pandemic warrants accelerated efforts to test vaccine candidates. We aimed to assess the safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidate, BBIBP-CorV, in humans. METHODS: We did a randomised, d...
Na minha lista:
| 發表在: | Lancet Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier Ltd.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7561304/ https://ncbi.nlm.nih.gov/pubmed/33069281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(20)30831-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|